Stride Velocity 95th Centile: Insights into Gaining Regulatory Qualification of the First Wearable-Derived Digital Endpoint for use in Duchenne Muscular Dystrophy Trials. (2022)

First Author: Servais L
Attributed to:  Oxford P2D: From Technologies to Therapies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3233/jnd-210743

PubMed Identifier: 34958044

Publication URI: http://europepmc.org/abstract/MED/34958044

Type: Journal Article/Review

Volume: 9

Parent Publication: Journal of neuromuscular diseases

Issue: 2

ISSN: 2214-3599